CURASYS 2 is a radiofrequency microneedling device designed to deliver RF energy through fine needles into the dermis, targeting skin laxity, wrinkles, and texture irregularities. The system heats tissue at depth while creating controlled micro-injuries to stimulate collagen remodeling.
For medspa owners, this represents another RF-microneedling option in a crowded category. The device's market entry means you'll want to evaluate how its specifications—needle depth, power settings, treatment time, and downtime profile—compare to Morpheus8, Secret, or other established platforms you may already offer. Consider whether the clinical outcomes, patient recovery experience, and pricing strategy justify adding another RF-microneedling system to your menu or switching from your current device.
See the FDA 510(k) summary for detailed specifications.
View the official FDA record ↗
This post summarizes a public FDA database entry for medical-aesthetics owners. It is general business information, not medical, legal, or regulatory advice. Always confirm scope, lot numbers, and classification against the official FDA record, and consult your own clinician or counsel for anything clinical or compliance-related.